Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial
Nicolas Garel, Sara de la Salle, Julien Thibault Lévesque, Alyssa Bensoussan, Juliette Vaugeois, David Erritzoe, Soham Rej, Michael Lifshitz, Stephane Richard-Devantoy, Kyle T. Greenway Communications Medicine
· Springer Nature
· 2026-11-14
· DOI: 10.1038/s43856-026-01987-8
Аннотация
Communications Medicine, Published online: 14 November 2026; doi:10.1038/s43856-026-01987-8 Garel et al. explore the influence of the personality trait absorption in the MUSIK trial which administered 181 doses of ketamine, with either music or mindfulness, for treatment-resistant depression. Higher absorption is associated with larger antidepressant effects, reduced suicidality, and more mystical experiences, especially with music-based support.
Nicolas Garel, Sara de la Salle, Julien Thibault Lévesque, Alyssa Bensoussan, Juliette Vaugeois, David Erritzoe et al. Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial. // Communications Medicine. – 2026. – DOI: 10.1038/s43856-026-01987-8. – URL: https://www.nature.com/articles/s43856-026-01987-8
Nicolas Garel, Sara de la Salle, Julien Thibault Lévesque, Alyssa Bensoussan, Juliette Vaugeois, David Erritzoe, Soham Rej, Michael Lifshitz, Stephane Richard-Devantoy, & Kyle T. Greenway (2026). Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial. Communications Medicine. https://doi.org/10.1038/s43856-026-01987-8
Nicolas Garel, et al. “Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial.” Communications Medicine, 2026. doi:10.1038/s43856-026-01987-8.
@article{Garel2026,
title = {Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial},
author = {Garel, Nicolas and Salle, Sara de la and Lévesque, Julien Thibault and Bensoussan, Alyssa and Vaugeois, Juliette and Erritzoe, David and Rej, Soham and Lifshitz, Michael and Richard-Devantoy, Stephane and Greenway, Kyle T.},
journal = {Communications Medicine},
year = {2026},
doi = {10.1038/s43856-026-01987-8},
url = {https://www.nature.com/articles/s43856-026-01987-8}
}
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Communications Medicine, Published online: 18 November 2026; doi:10.1038/s43856-026-01992-x ED Summary: O’Connor et al. use a patient-derived organoid co-culture platform to evaluate engineered bacterial therapies for colorectal cancer...
Communications Medicine, Published online: 17 November 2026; doi:10.1038/s43856-026-02012-8 Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst
Communications Medicine, Published online: 16 November 2026; doi:10.1038/s43856-026-01727-y Ozawa et al. simulated the impact of misinformation in Canada on individuals delaying and refusing vaccination during the COVID-19 pandemic....